Evans, D Gareth R
AffiliationAcademic Unit of Medical Genetics and Regional Genetics Service, St Mary's Hospital, Manchester M13 0JH, UK.
MetadataShow full item record
AbstractDifferences in reported uptake of genetic testing for mutations in BRCA1 and BRCA2 can largely be accounted for by different methodologies and by studying research vs nonresearch families. In our joint study of 75 nonresearch families from two UK centres in which at least 3 years had elapsed since the initial proband had been informed of the availability of testing, only 45 and 34% of eligible individuals from Manchester and London, respectively, had come forward for counselling. Final uptake rates using a non-proactive approach were 53 and 29% for women and 11-12% for men, but the figure among those attending clinic was 73 and 62%, respectively. Unlike previous studies, we did not find that uptake had stabilised after a year with 25% of those being tested more than 2 years after the family was informed, and several delaying a considerable time between genetics appointments. We believe that the particularly low uptake even of counselling in men may need to be addressed by improving family communication or providing information sheets for family members to disseminate.
CitationBRCA1/2 predictive testing: a study of uptake in two centres. 2004, 12 (8):654-62 Eur. J. Hum. Genet.
JournalEuropean Journal of Human Genetics
- Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations.
- Authors: Finlay E, Stopfer JE, Burlingame E, Evans KG, Nathanson KL, Weber BL, Armstrong K, Rebbeck TR, Domchek SM
- Issue date: 2008 Mar
- Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
- Authors: Armstrong K, Micco E, Carney A, Stopfer J, Putt M
- Issue date: 2005 Apr 13
- Cascade screening in BRCA1/2 mutation carriers.
- Authors: Cody N, Green A, McDevitt T, Lynch SA
- Issue date: 2008 May
- Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
- Authors: Meijers-Heijboer H, Brekelmans CT, Menke-Pluymers M, Seynaeve C, Baalbergen A, Burger C, Crepin E, van den Ouweland AW, van Geel B, Klijn JG
- Issue date: 2003 May 1
- Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.
- Authors: Armstrong J, Toscano M, Kotchko N, Friedman S, Schwartz MD, Virgo KS, Lynch K, Andrews JE, Aguado Loi CX, Bauer JE, Casares C, Bourquardez Clark E, Kondoff MR, Molina AD, Abdollahian M, Walker G, Sutphen R
- Issue date: 2015 Dec